Renault shares plunge 16% after French carmaker lowers guidance, appoints new interim CEO

Renault shares plunge 16% after French carmaker lowers guidance, appoints new interim CEO


A Renault Espace E-Tech full Hybrid (L) and a Megane E-Tech 100% Electric EV (C) are displayed during the Geneva Motor Show 2024 at Palexpo on Feb. 26, 2024 in Geneva, Switzerland. 

John Keeble | Getty Images News | Getty Images

Shares of French carmaker Renault plunged as much as 17% on Wednesday after the company lowered its 2025 guidance and announced the appointment of a new interim chief executive officer.

The Paris-listed stock was last seen trading down 15.6%, notching a fresh 52-week low. It puts the company on track for its worst trading day since March 2020.

In a trading update published late Tuesday, Renault said it is targeting an operating margin of around 6.5% this year, down from a previous forecast of around or exceeding 7%.

The company is also aiming for a free cash-flow between 1 billion euros ($1.16 billion) and 1.5 billion euros, down from roughly or above 2 billion euros, previously.

Renault also announced the appointment of Duncan Minto as interim CEO, following Luca de Meo’s abrupt resignation last month after around five years at the helm of the company.

“Currently CFO of Renault Group, Duncan Minto will ensure the day-to-day management of the company alongside Jean-Dominique Senard, who will hold the position of Chairman of Renault s.a.s., the operating company of the Group, during this period,” Renault said in a statement.

Renault is poised to report its half-year results on July 31.

Analysts at Germany’s Deutsche Bank cut their target price to 47 euros, down from 55 euros, on news of Renault’s profit warning.

“While the new margin guide remains solid also relative to peers, we see the warning as an obvious additional hit on sentiment for shares,” analysts at Deutsche Bank said in a research note.

Analysts at JPMorgan, meanwhile, said Renault’s new management structure would face further challenges from muted demand in Europe, ongoing trade tensions and rising competition from Chinese manufacturers.

— CNBC’s Jordan Butts contributed to this report.



Source

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
World

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance

Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight.  LifeMD went from seeing […]

Read More
Circle jumps 16% on Clarity Act compromise that preserves stablecoin rewards
World

Circle jumps 16% on Clarity Act compromise that preserves stablecoin rewards

Circle Internet Group Initial Public Offering at the New York Stock Exchange in New York City, U.S., June 5, 2025. NYSE Shares of Circle surged after lawmakers over the weekend struck a compromise on the market structure bill known as the CLARITY Act, preserving stablecoin reward programs under certain conditions. On Friday, key language in […]

Read More
‘Misplaced euphoria’: Markets are sleepwalking into a recession amid Iran war oil price shock
World

‘Misplaced euphoria’: Markets are sleepwalking into a recession amid Iran war oil price shock

Global economies could be “sleepwalking” into a “big recession”, as investors continue to underplay the impact of the oil price shock, Amrita Sen, founder and director, market intelligence at Energy Aspect, told CNBC’s “Squawk Box Europe” on Monday. The S&P 500 hit a new all-time intraday high last week, with the broad market index touching […]

Read More